Home » MEDTRONIC RECEIVES FDA APPROVAL FOR ITS CONCERTO/VIRTUOSO LINE OF IMPLANTABLE CARDIAC DEVICES
MEDTRONIC RECEIVES FDA APPROVAL FOR ITS CONCERTO/VIRTUOSO LINE OF IMPLANTABLE CARDIAC DEVICES
May 17, 2006
Medtronic Inc. announced that it received FDA approval of its Concerto/Virtuoso line of implantable cardiac devices, its next generation of cardiac rhythm disease management products.
Trading
Markets Live
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
21Oct